Fig. 6 | Scientific Reports

Fig. 6

From: Clinical outcomes of endocrine and other disorders induced by immune checkpoint inhibitors in Japanese patients

Fig. 6

(A) Kaplan-Meier curves for each malignancy by participant were created and log-rank tests were performed. (B) Overall survival (OS) for each malignancy by participant. The Kruskal-Wallis test was used for analysis. **p < 0.005, ***p < 0.001. (C) Remission rate, (D) incidence of each irAE. The remission rate and the incidence of each irAE were analyzed using the chi-square test. NSCLC; non-small cell lung cancer, GIT; gastrointestinal tumor, HCC; hepatocellular carcinoma, OLT; otolaryngological tumor, UTC; urotherial carcinoma, MM; malignant melanoma, RCC; renal cell carcinoma, SCLC; small cell lung cancer, PD; progressive disease, SD; stable disease, PR; partial remission, CR; complete remission.

Back to article page